Медицинская литература. Новинки

 

 

 

 

 

 

СЕЛЕН И ЩИТОВИДНАЯ ЖЕЛЕЗА

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Abalovich M., Llesuy S., Gutierrez S. et al. Peripheral parameters of
oxidative stress in Graves' disease: the effects of methimazole and
131 iodine treatments // Clin. Endocrinol. 2003. V. 59. P. 321–327.
2. Ademoglu E., Ozbey N., Erbil Y. et al. Determination of oxidative
stress in thyroid tissue and plasma of patients with Graves' disease // Eur. J. Intern. Med. 2006. V. 17. P. 545–550.
3. Al Kunani A.S., Knight R., Haswell S.J. et al. The selenium status of
women with a history of recurrent miscarriage // Brit. J. Obstet.
Gynaecol. 2001. V. 108. P. 1094–1097.
4. Arner E.S., Holmgren A. Physiological functions of thioredoxin and
thioredoxin reductase // Eur. J. Biochem. 2000. V. 267.
P. 6102–6109.
5. Bacic$Vrca V., Skreb F., Cepelak I. et al. The effect of antioxidant
supplementation on superoxide dismutase activity, Cu and Zn
levels, and total antioxidant status in erythrocytes of patients with
Graves' disease // Clin. Chem. Lab. Med. 2005. V. 43. P. 383–388.
6. Bates J.M., Spate V.L., Morris J.S. et al. Effects of selenium deficiency on tissue selenium content, deiodinase activity, and thyroid hormone economy in the rat during development //
Endocrinol. 2000. V. 141. P. 2490–2500.
7. Beckett G.J., Arthur J.R. Selenium and endocrine system //
J. Endocrinol. 2005. V. 184 (3). P. 455–465.
8. Bianco A.C., Kim B.W. Deiodinases: implications of the local control of the thyroid hormone action // J. Clin. Invest. 2006. V. 116.
P. 2571–2579.
9. Bianco A.C., Salvatore D., Gereben B. et al. Biochemistry, cellular
and mo-lecular biology, and physiological roles of the iodothyronine selenodeiodinases // Endocr. Rev. 2002. V. 23. P. 38–89.
10. Birringer M., Pilawa S., Flohe L. Trends in selenium biochemistry // Nat. Prod. Rep. 2002. V. 19. P. 693–718.
11. Bjorkman U., Ekholm R. Hydrogen peroxide degradation and glutathione per-oxidase activity in cultures of thyroidal cells // Mol.
Cell. Endocr. 1995. V. 111. P. 99–107.
12. Bleys J., Miller E.R., Pastor$Barriuso R. et al. Vitamin-mineral supplementation and the progression of atherosclerosis: a metaanalysis of randomized controlled trials // Am. J. Clin. Nutr.
2006. V. 84. P. 880–887.
13. Boyages S.C. Iodine deficiency disorders // J. Clin. Endocrinol.
Metab. 1993. V. 77. P. 587-591.
14. Brown M.R., Cohen H.J., lyons J.M. Proximal muscle weakness and
selenium deficiency associated with long-term parental nutrition // Idid. P. 549–554.
15. Castellano S., Lobanov A.V., Capple C. et al. Diversity and functional plasticty of eukaryotic selenoproteins: identification and
characterization of the Sel family // Proc. Natl. Acad. Sci USA.
2005. V. 102. P. 16188–16193.
16. Caturegli P., Kimura H., Rocchi R. et al. Autoimmune thyroid diseases // Curr. Opin. Rheumatol. 2007. V. 19. P. 44–48.
17. Conrad M., Jakupoglu C., Moreno S.G. et al. Essential role for
mitochondrial thioredoxin reductase in hematopoiesis, heart
development, and heart function // Mol. Cell. Biol. 2004. V. 24.
P. 9414–9123.
18. Contempre B., de Escobar G.M., Denef J.F. Thiocyanate induces
cell necrosis and fibrosis in selenium and iodinedeficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in Central Africa // Endo-crinol. 2004. V. 145.
P. 994–1002.
19. Contempre B., Dumont J.E., Denef J.$F., Many M.C. Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a
possible role in myxoedematous cretinism // Eur. J. Endocrinol.
1995. V. 133. P. 99–109.
20. Contempre B., Le Moine O., Dumont J.E. Selenium deficiency and
thyroid fibrosis. A key role for macrophages and transforming
growth factor β (TGF-β) // Mol. Cell. Endocr. 1996. V. 124.
P. 7–15.
21. Contempré B., Duale N.L., Dumont J.E. et al. Effect of selenium
supple-mentation on thyroid hormone metabolism in an iodine
and selenium deficient population // Clin. Endocr. 1992. V. 36.
P. 579–583.
22. ContempréB., Jauniaux E., Calvo R. et al. Detection of thyroid
hormones in human embryonic cavities during the first trimester of
pregnancy // J. Clin. Endocr. Met. 1993. V. 77. P. 1719–1722.
23. Corvilain B., Collyn L., van Sande J. et al. Stimulation by iodide of
H2O2 generation in thyroid slices from several species // Am. J.
Physiol. Endocr. Met. 2000. V. 278. P. 692–699.
24. Dayan C.M., Daniels G.H. Chronic autoimmune thyroiditis //
N. Engl. J. Med. 1996. V. 335. P. 99–107.
25. Delange F. Cassava and the thyroid. In: Gaitan E, ed.
Environmental goitrogenesis. Boca Raton, FL. CRC Press: 1989.
P. 173–194.
26. Derumeaux H., Valeix P., Castetbon K. et al. Association of selenium with thyroid volume and echostructure in 3-to 60-year-old
French adults // Eur. J. Endocr. 2003. V. 148. P. 309–315.
27. Dumitrescu A.M., Liau X.H., Abdullah M.S. et al. Mutations in
SECISBP2 result in abnormal thyroid hormone metabolism //
Nat. Genet. 2005. V. 37. P. 1247–1252.
28. Duntas L.H., Mantzou E., Koutras D.A. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis // Eur. J. Endocr. 2003. V. 148. P. 389–393.
29. Ekholm R., Bjorkman U. Glutathione peroxidase degrades intracellular hydrogen peroxide and thereby inhibits intracellular protein
iodination in thyroid epithelium // Endocrinol. 1997. V. 138.
P. 2871–2878.
30. Farber J.L., Kyle M.E., Coleman J.B. Mechanisms of cell injury by
activated oxygen species // Lab. Invest. 1990. V. 62. P. 670–679.
31. Garland M., Morris J.S., Stampfer M.J. et al. Prospective study of
toenail selenium levels and cancer among women // J. Natl.
Cancer Inst. 1995. V. 87. P. 497–505.
32. Gärtner R., Gasnier B.C., Dietrich J.W. et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid
peroxidase antibodies concentrations // J. Clin. Endocr. Met.
2002. V. 87. P. 1687–1691.
33. Gärtner R., Gasnier B.C. Selenium in the treatment of autoimmune
thyroiditis // Biofactors. 2003. V. 19. Р. 165–170.
34. Golubkina N., Alftban G. The human selenium status in 27 regions
of Russia // J. Trace Elem. Med. Biol. 2000. V. 13. P. 15–20.
35. Guerra L.N., Ríos de Molina Mdel C., Miler E.A. et al. Antioxidants
and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels // Clin. Chim. Acta. 2005. V. 352.
P. 115–120.
36. Hunter D.J., Morris J.S., Stampfer M.J. et al. A prospective study of
selenium status and breast cancer risk // J.A.M.A. 1990. V. 264.
P. 1128–1131.
37. Imai H., Nakagava Y. Biological significance of phospholipid
hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells // Free Rad. Biol. Med. 2003. V. 34. P. 145–169.
38. Kohrle J., Jakob F., Contempre B., Dumont J.E. Selenium, the
Thyroid, and the Endocrine System // Endocr. Rev. 2005. V. 26
(7). P. 944–984.
39. Jakupoglu C., Przemeck G.K., Schneider M. et al. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development // Mol. Cell. Biol. 2005. V. 25. P. 1980–1988.
40. Kihara M., Kontani K., Yamauchi A. et al. Expression of thioredoxin in patients with Graves disease // Int. J. Mol. Med. 2005.
V. 15. P. 795–799.
41. Kim H., Park S., Suh J.M. et al. Thyroid-stimulating hormone
transcription-ally regulates the thiol-specific antioxidant gene //
Cell. Physiol. Biochem. 2001. V. 11. P. 247–252.
42. Kimura T., Okajima F., Sho K. et al. Thyrotropin-induced hydrogen peroxide producrion in FRTL-5 thyroid cells is mediated not
by adenosine 3',5'-monophosphate, but by Ca2+ signalling followed by phospholipase-A2 activation and potentiated by an
adenosine derivative // Endocrinol. 1995. V. 136. P. 116–123.
43. Klecha A.J., Barreiro Arcos M.L., Frick L. et al. Immune-endocrine
interactions in autoimmune thyroid diseases //
Neuroimmunomodulat. 2008. V. 15(1). P. 68–75.
44. Koenig R.J. Regulation of type 1 iodothyronine deiodinase in
health and disease // Thyroid. 2005. V. 15. Р. 835840.
45. Kohrle J. The deiodinase family : selenlenoenzymes regulating thyroid hormone availability and action // Cell. Mol. Life Sci. 2000.
V. 57. P. 1853–1863.
46. Kohrle J., Jakob F., Contempre B. et al. Selenium, the thyroid, and
the endocrine system // Endocr. Rev. 2005. V. 26. Р. 944-984.
47. Kohrle J. The trace element selenium and the thyroid gland //
Biochim. 1999. V. 81. P. 383–387.
48. Kryukov G.V., Castellano S., Novoselov S.V. et al. Characterization
of mam-malian selenoproteomes // Science. 2003. V. 300.
P. 1439–1443.
49. Kumar S., Bjornstedt M., Holmgren A. Selenite is a substrate for calf
thymus thioredoxin reductase and thioredoxin and elicits a large
non-stoichiometric oxidation of NADPH in the presence of oxygen // Eur. J. Biochem. 1992. V. 207. P. 435–439.
50. Leonard J.L., Rosenberg I.N. Thyroxine 5'-deiodinase activity of
rat kidney. Observations on activation by thiols and inhibition by
propylthiouracil // Endocrinol. 2003. V. 103. P. 2137–2144.
51. Levander O.A., Beck M.A. Interacting nutritional and infectious
etiologies of Keshan disease: insights from Coxackie virus B-induced myocarditis in mice deficient in selenium or vitamin Е //
Biol. Trace Elem. Res. 1997. V. 56. P. 5–21.
52. Ma T., Guo J., Wang F. The epidemiology of iodine-deficiency diseases in China // Am. J. Clin. Nutr. 1993. V. 57. P. 264S–266S.
53. Matsui M., Oshima M., Oshima H. et al. Early embryonic lethality
caused by targeted disruption of the mouse thioredoxin gene //
Dev. Biol. 1996. V. 178. P. 179–185.
54. Mazopakis E.E., Papadakis J.A., Papadomanolaki M.G. et al.
Effects of 12 months treatment with L-selenomethionine on serum
anti-TPO levels in patients with Hashimoto's thyroiditis //
Thyroid. 2007. V. 17. P. 609–612.
55. Moncayo R., Moncayo H. Nutritional treatment of incipient thyroid autoimmune disease. Influence of selenium supplementation
on thyroid function and morphology in children and young
adults // Clin. Nutr. 2005. V. 24. P. 530–531.
56. Moreno-Reyes R., Mathieu F., Boelaert M. et al. Selenium and
iodine supplementation of rural Tibetan children affected by
Kashin-Beck osteoarthropathy // Am. J. Clin. Nutr. 2003. V.78.
P. 137–144.
57. Moreno$Reyes R., Suetens C., Mathieu F. et al. KashinBeck disease and iodine deficiency in Tibet 1998 // N. Eng. J. Med.
V. 339. P. 1112–1120.
58. Negro R., Formoso G., Mangieri T. et al. Levothyroxine treatment
in euthyroid pregnant women with autoimmune thyroid disease:
effects on obstetrical complications // J. Clin. Endocr. Met. 2006.
V. 91. P. 2587–2591.
59. Negro R., Greco G., Mangieri T. et al. The influence of selenium
supplemen-tation on postpartum thyroid status in pregnant women
with thyroid peroxidase autoantibodies // J. Clin. Endocrinol.
Metab. 2007. V. 92. P. 1263–1268.
60. Negro R. Selenium and thyroid autoimmunity // Targ. Therap.
2008. V. 2(2). P. 265–273.
61. Nève J. Methods in determination of selenium states // J. Trace
Elem. Electrolyt. Heal. Dis. 1991. V. 5(1). P. 1–17.
62. Nomura K., Imai H., Nakagava Y. Involvment of mitochondrial
phospholipid hydroperoxide glutathione peroxidase as an anti-apoptotic factor // Biol. Sign. Recept. 2001. V. 10. P. 81–92.
63. Nonn L., Williams R.R., Erickson R.P. et al. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly,
and early embryonic lethality in homozygous mice // Mol. Cell.
Biol. 2003. V. 23. P. 916–922.
64. Peg A., Yang C., Rui H., Li H. Study on the patogenetic factors of
Kashin-Beck disease // J. Toxicol. Environ.Heal. 1992. V. 35.
P. 79–90.65. Poppe K., Glinoer D. Thyroid autoimmunity and hypothyroidism before
and during pregnancy // Hum. Reprod. Update. 2003. V. 9. P. 149–161.
66. Prummel M.F., Wiersinga W.M. Thyroid autoimmunity and miscarriage // Eur. J. Endocr. 2004. V. 150. P. 751–755.
67. Rayman M.P. The importance of selenium to human health //
Lancet. 2000. V. 356. P. 233–241.
68. Seven R., Gelisgen R., Seven A. et al. Influence of propylthiouracil
treatment on oxidative stress and nitric oxide in Basedow disease
patients // J. Toxicol. Env. Heal. 2001. V. 62. P. 495–503.
69. Smyth P.P. Role of iodine in antioxidant defence in thyroid and
breast disease. // Biofact. 2003. V. 19. P. 121–130.
70. St. Germain D.L., Hernandez A., Schneider M.J. et al. Insights into
the role of deiodinases from studies of genetically modified animals // Thyroid. 2005. V. 15. Р. 905–916.
71. Stagnaro$Green A. Postpartum thyroiditis // Best Pract. Res. Clin.
Endocr. Met. 2004. V. 18. P. 303–316.
72. Stawicki S.P., Lyons M., Aloupis M. et al. Current evidence from
phase III clinical trials of selenium supplementation in critically ill
patients: why should we bother? // Mini Rev. Med. Chem. 2007.
V. 7. P. 693–639.
73. Stranges S., Marshall J.R., Natarajan R. et al. Effects of long-term
selenium supplementation on the incidence of type 2 diabetes: a
randomized trial // Ann. Intern. Med. 2007. V. 147. P. 217–223.
74. Strieder T.G., Prummel M.F., Tijssen J.G. et al. Risk factors for and
prevalence of thyroid disorders in a crosssectional study among
healthy female relatives of patients with autoimmune thyroid disease // Clin. Endocrin. 2003. V. 59. P. 396–401.
75. Sun Q.A., Kirnarsky L., Sherman S. et al. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems //
Proc. Natl. Acad. Sci USA. 2001. V. 98. P. 3673–3678.
76. Sun Q.A., Wu Y., Zappacosta F. et al. Redox regulation of cell signalling by selenocysteine in mammalian thioredoxin reductases //
J. Biol. Chem. 1999. V. 274. P. 24522–24530.
77. Surai P. Selenium in nutrition and health Nottingham: Univ.
Press, 2006.
78. Vanderpas J.B., Contemprè B., Duale N.L. Iodine and selenium
deficiency associated with cretinism in Zaire // Am. J. Clin. Nutr.
1990. V. 52. P. 1087–1093.
79. Wertenbruch T., Willenberg H.S., Sagert C. et al. Serum selenium
levels in patients with remission and relapse of Graves' disease //
Med. Chem. 2007. V. 3. P. 281–284.
80. Xia Y., Hill K.E., Byrne D.W. et al. Effectiveness of selenium supplements in a low-selenium area of China // Am. J. Clin. Nutr.
2005. V. 81. P. 829–834.
81. Yang G.Q., Xia Y.M. Studies on human dietary requirements and
safe rang of dietary intakes of selenium in China and their application in the prevention of related endemic diseases // Biomed.
Environ. Sci. 1995. V. 8. P. 187–201.
82. Голубкина Н.А., Шагова М.В. Уровень потребления селена беременными женщинами некоторых регионов России и
стран СНГ / Тез. Докл. Всерос. конф. “Питание детей 21 века”. М., 2000. С. 28.
83. Тутельян В.А., Княжев В.А., Хотимченко и др. Селен в организме человека. М: Изд. РАМН, 2002. С. 30–31.

Keywords: